Studying a rare disorder that also causes autism in 25-50 percent of affected patients, new research supports the emerging idea that autism results from disrupted brain “connectivity” causing improper information flow. These abnormalities might be reversible with rapamycin or rapamycin-like drugs, which the studies researchers will be bringing to clinical trial later this year.